Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GSK-4172239D by GSK for Sickle Cell Disease: Likelihood of Approval
GSK-4172239D is under clinical development by GSK and currently in Phase I for Sickle Cell Disease. According to GlobalData, Phase...